<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01829022</url>
  </required_header>
  <id_info>
    <org_study_id>NCCNCS-13-MAR</org_study_id>
    <nct_id>NCT01829022</nct_id>
  </id_info>
  <brief_title>Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures</brief_title>
  <acronym>E-NOTES</acronym>
  <official_title>Multi-center Prospective Study on Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy With Traction of Multidirectional Sutures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Vincent's Hospital, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Incheon St.Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kyung Hee University Hospital at Gangdong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cheil General Hospital and Womenâ€™s Healthcare Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Health Insurance Service Ilsan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Soonchunhyang University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ajou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Yangsan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ewha Womans University Mokdong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHA University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kyungpook National University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objectives : To investigate technical feasibility and postoperative morbidity after
      E-NOTES for Myomectomy with Traction of Multidirectional Sutures

      Secondary objectives : To investigate postoperative pain after E-NOTES for Myomectomy with
      Traction of Multidirectional Sutures by clinical variables such as incision size, type of
      port, size and number of myoma, or operation time.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Leiomyoma is a common benign tumor of the smooth muscle cells of the myometrium.1 It can
           cause several symptoms such as abnormal vaginal bleeding, pain, or urinary symptoms
           according to size and location. Steadily, lesser invasive surgeries have been preferred
           for such benign disease (laparotomy, laparoscopy, and then single-port surgery).2,3

        -  However, these minimal approaches, laparoscopic morcellation of preoperatively
           suspicious leimyoma, have the potential risk of peritoneal seeding of postoperative
           diagnosed leiomyosarcoma in the pathological examination.4 Currently, safe morcellation
           is also required during myomectomy while using a lesser invasive surgical approach such
           as single-port surgery or natural orifice transumbilical endoscopic surgery (NOTES).

        -  During single-port surgery or embryonic NOTES (E-NOTES) via an umbilicus, handling of
           myoma into different directions could be quite a big challenge. Fortunately, myoma is
           enough hard to pull with string and has a tendency not to rupture during manipulation of
           these strings.

        -  These concepts lead to traction of anchoring sutures during E-NOTES for myomectomy
           applied in the current case. Safe morcellation could be guaranteed, because direction
           morcellation via an umbilicus is possible in an endobag.

        -  This useful and safe surgical approach needs to be confirmed in multi-centers in terms
           of feasibility and morbidity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Technical feasibilities and postoperative morbidity after E-NOTES for Myomectomy with Traction of Multidirectional Sutures</measure>
    <time_frame>Postoperative surveillance including pain evaluation as routine clinical practise for 1 months</time_frame>
    <description>Technical feasibility and postoperative morbidity will be evaluated in terms of overall or institutional conversion rate to convetional multi-port laparoscopy or laparotomy, operation time for each surgical procedures: dissection, morecellation, suturing, and total surgical procedures, complication, change of hemoglobin, and estimated blood loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain after E-NOTES for Myomectomy with Traction of Multidirectional Sutures by clinical variables such as incision size, type of port, size and number of myoma, or operation time.</measure>
    <time_frame>Preoperative and postoperative pain</time_frame>
    <description>Visual analogue scale will be used for pain evaluation: preoperative, postoperative 24 hour, postoperative 48 hour, postoperative 10 day (7 to 10 day), and postoperative 28 day (21 to 35 day).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Myoma</condition>
  <arm_group>
    <arm_group_label>E-NOTES</arm_group_label>
    <description>Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy with Traction of Multidirectional Sutures</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>E-NOTES</intervention_name>
    <description>Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy with Traction of Multidirectional Sutures</description>
    <arm_group_label>E-NOTES</arm_group_label>
    <other_name>Embryonic-Natural Orifice Transumbilical Endoscopic Surgery</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with myoma which are surgically candidate at educational hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who are surgically candidate for myomectomy

          -  Age &gt; 20 years

        Exclusion Criteria:

          -  Contraindications for laparoscopic surgery and/or general anesthesia.

          -  Greater than five fibroids sized of 3cm or more

          -  Uterus extending beyond the umbilicus

          -  Major medical comorbidity or psychiatric illness, which could affect follow-up and/or
             compliance

          -  Patients undergoing concomitant complex surgical procedures at the time of myomectomy
             (such as resection of severe endometriosis etc.)

          -  Pregnancy

          -  Patients with any suggestion of malignancy in the pelvis

          -  Patients with cooperation of another main surgical procedures such as severe
             adhesiolysis or low anterior resection

          -  Patients who are severely anemic or who have significant medical conditions such as
             cardiac or pulmonary disease

          -  Patients who refuse to participate or give consent to the procedures
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myong Cheol Lim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Koyang-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2013</study_first_posted>
  <last_update_submitted>June 24, 2014</last_update_submitted>
  <last_update_submitted_qc>June 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Myong Cheol Lim</investigator_full_name>
    <investigator_title>Senior researcher</investigator_title>
  </responsible_party>
  <keyword>Myoma</keyword>
  <keyword>Uterine myomectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

